Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs

Cells. 2022 Jul 30;11(15):2352. doi: 10.3390/cells11152352.

Abstract

Cancer stem cells are a cell population within malignant tumors that are characterized by the ability to self-renew, the presence of specific molecules that define their identity, the ability to form malignant tumors in vivo, resistance to drugs, and the ability to invade and migrate to other regions of the body. These characteristics are regulated by various molecules, such as lncRNAs, which are transcripts that generally do not code for proteins but regulate multiple biological processes through various mechanisms of action. LncRNAs, such as HOTAIR, H19, LncTCF7, LUCAT1, MALAT1, LINC00511, and FMR1-AS1, have been described as key regulators of stemness in cancer, allowing cancer cells to acquire this phenotype. It has been proposed that cancer stem cells are clinically responsible for the high recurrence rates after treatment and the high frequency of metastasis in malignant tumors, so understanding the mechanisms that regulate the stem phenotype could have an impact on the improvement of cancer treatments.

Keywords: long non-coding RNA; microenvironment; stem cancer cells; stem phenotype.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Mental Retardation Protein / metabolism
  • Humans
  • Neoplasms* / metabolism
  • Neoplastic Stem Cells / pathology
  • Phenotype
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • FMR1 protein, human
  • RNA, Long Noncoding
  • Fragile X Mental Retardation Protein

Grants and funding

This research was funded by CONACyT grant number A1-S-8462. Adan Gutierrez was supported by a scholarship from CONACyT.